Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belboul, A.
Right arrow Articles by Johnsson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belboul, A.
Right arrow Articles by Johnsson, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 16, No. 1, 59-65 (2001)
DOI: 10.1177/026765910101600109

Oxygen free radical generation in healthy blood donors and cardiac patients: the protective effect of allopurinol

Ali Belboul

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg

Donald Roberts

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg

Richard Börjesson

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg

Joakim Johnsson

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg

Cardiopulmonary bypass (CPB) activates the complement system, which leads to granulocyte activation and free radical production. Free radical activity during CPB has been associated with myocardial dysfunction. However, the relationship between cardiac enzymes and granulocytes to lipid peroxidation in cardiac surgery patients is unknown. Moreover, the effect of allopurinol on lipid peroxidation during mechanical trauma has to be explored.

Thirty-four patients undergoing coronary bypass surgery and 26 healthy blood donors participated in this prospective study where granulocyte counts, cardiac enzymes and malondialdehyde (MDA) were measured and related. Allopurinol was used ex vivo, as scavenger, to explore its effect on lipid peroxidation.

In the patient group, the mean preoperative MDA level (2.2 ± 0.7, nmol/ml) significantly increased after 30 min of bypass (3.3 ± 0.9 nmol/ml; p < 0.0001), and showed a second peak at aortic declamping (4.1 ± 0.9 nmol/ml). There were significant correlations between MDA and granulocyte counts (r = 0.59, p < 0.0001) and cardiac enzymes (r = 0.55, p < 0.0001). In an ex vivo setting, further mechanical trauma to blood significantly increased the MDA levels, both in the control (p < 0.0001) and in the patient group (p < 0.0001) and this effect could be reduced by allopurinol (p < 0.0001). CPB and mechanical trauma generate oxygen free radicals. Allopurinol was found to reduce lipid peroxidation of red cells following mechanical trauma and this has to be further investigated regarding its ability to reduce morbidity in patients undergoing open heart surgery.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Schultz, D. Antoni, G. Shears, S. Markowitz, P. Pastuszko, W. Greeley, D. F. Wilson, and A. Pastuszko
Brain oxygen and metabolism during circulatory arrest with intermittent brief periods of low-flow cardiopulmonary bypass in newborn piglets
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 839 - 844.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Dodd-o, L. E. Welsh, J. D. Salazar, P. L. Walinsky, E. A. Peck, J. G. Shake, D. J. Caparrelli, R. C. Ziegelstein, J. L. Zweier, W. A. Baumgartner, et al.
Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H927 - H936.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Schultz, J. Creed, G. Schears, T. Zaitseva, W. Greeley, D. F. Wilson, and A. Pastuszko
Comparison of low-flow cardiopulmonary bypass and circulatory arrest on brain oxygen and metabolism
Ann. Thorac. Surg., June 1, 2004; 77(6): 2138 - 2143.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
U. M. Fischer, C. S. Cox Jr, S. J. Allen, R. H. Stewart, U. Mehlhorn, and G. A. Laine
The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1483 - 1488.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
N. A Weimert, W. F Tanke, and J J. Sims
Allopurinol as a Cardioprotectant During Coronary Artery Bypass Graft Surgery
Ann. Pharmacother., November 1, 2003; 37(11): 1708 - 1711.
[Abstract] [Full Text] [PDF]